All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2172 | Anti-MELK (OTSMAb01) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | OTSMAb01 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2173 | Anti-MELK (CBFYM-2049) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2049 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2174 | Anti-MELK (CBFYM-2050) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2050 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2175 | Anti-MELK (CBFYM-2051) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2051 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2176 | Anti-MELK (CBFYM-2052) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2052 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5425 | Anti-MELK (OTSMAb01) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | OTSMAb01 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5426 | Anti-MELK (CBFYM-2049) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2049 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5427 | Anti-MELK (CBFYM-2050) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2050 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5428 | Anti-MELK (CBFYM-2051) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2051 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5429 | Anti-MELK (CBFYM-2052) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2052 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION